All Blogs

Nov 19, 2019

Novo Nordisk has announced to enter into a collaboration with Dicerna’s RNAi platform to focus on metabolic and liver-related diseases. The companies will be focusing to advance the treatment landscape of the diseases such as non-alcoholic steatohepatitis (NASH), Type 2 diabetes and obesity. Nordisk will be inv...

Nov 18, 2019

As per DelveInsight’s estimates, total Complex Regional Pain Syndrome cases in the 7MM were found to be 253,603 in 2017. The United States accounted for the highest CRPS prevalent population with 179,441 cases. In terms of European countries, Germany recorded for the highest Complex regional pain syndrome preva...

Nov 15, 2019

Levels of air pollution have risen dramatically over the past years due to increasing outdoor human activities such as industrialization, urbanization and indoor activities like burning of solid fuels, coal, etc. This has contaminated the air we breathe with several harmful substances such as Sulfur dioxide (SO2), ...

Nov 14, 2019

AbbVie has traded off its bonds worth USD 30 Billion to finance the purchase of the Allergan.   AbbVie this year in June has agreed to buy Allergan for USD 63 Billion, which is one of the largest deals this year. The acquisition will help AbbVie to diversify its drug portfolio which mostly revolves around H...

Nov 14, 2019

World Diabetes Day, observed on 14 November every year, aiming to raise awareness about the impact that diabetes has on the family. This year, the theme this day is Family and Diabetes. World Diabetes Day  According to a survey by WHO, 425 million people are still struggling with diabetes, and by th...

Nov 13, 2019

Thalassemia is a group of inherited blood disorders that are a result of defects or mutations in the genes. The defect results in defective or less production of the haemoglobin, thus hampering the transport of the oxygen to all the body parts. The most common form of the thalassemia is Beta-Thalassemia. It cau...

Nov 12, 2019

The US FDA for the third time has refused to give approval to Lipocine’s oral testosterone drug, Tlando. The drug is an oral testosterone replacement therapy in clinical trials for the treatment of Primary and Secondary hypogonadism in males. The drug contains containing Testosterone Undecanoate (TU) which help...

Dec 24, 2024

Parkinson’s disease is a complex neurodegenerative disorder that affects millions worldwide, with increasing prevalence as populations age. The market for Parkinson’s disease treatments is expanding rapidly, driven by rising awareness of what Parkinson’s disease is, advancements in research, and improvements in hea...

Nov 08, 2019

Pancreas is a gland which has two components exocrine component and endocrine component.  The exocrine component which is responsible for making proteins/ enzymes and releasing them into small intestines for easy digestion. On the other hand, the endocrine component of the pancreas is responsible for making ho...

Nov 07, 2019

Switzerland-based Vifor Pharma and Germany-based Evotech AG have collaborated for the development and discovery of new treatments for kidney diseases. The launch of a new 50:50 joint venture will be focused on developing nephrology pipeline utilizing Evotec’s UK kidney biobank, NURTuRE. Under the terms of the a...